Grupo de Estudo de Cardio-Oncologia

GECO's mission is to develop Cardio-Oncology in Portugal, promoting links between centres, postgraduate training and research.

[Grupo de Estudo de Cardio-Oncologia @GecoSpc]

Webinar "Cardiology meets Hematology"
Join us on nov. 5th!
A unique opportunity to learn from national and international experts!
@spcardio
@SHematologia
@arjunkg
@awechalekar
@toste_julia
@ManuelaFiuza5
@Mariana68137947
@ReemLaymouna

Registration https://t.co/OYljw9UCb9

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🎙️🚨New Podcast Alert!
How can cancer therapy impact blood pressure and vascular health?🩺❤️‍🩹
In our latest episode, Prof. Pietro Ameri 🇮🇹 and @LlamedoClara🇬🇧dive into “Hypertension and Vascular Toxicity in Cancer Therapy” #CardioOncology @ESC_Lavinia @TeresaLpezFdez1

[Carla de Sousa @cmcsousa]

ICI myocarditis is part of a sistemic myopathic process and mortality might be caused respiratory muscle failure. Prof. Joe-Elie Salem explained how to diagnose this cases and how abatacept can be useful and effective!
@mnobremenezes
#CPC2026
#CPCInMotion

[Miguel Nobre Menezes @mnobremenezes]

Cancer patients are a growing cardiology population. Are we ready for them? 🫀

#CPC2026 is tackling cardio-oncology head on today — rehab, sudden death risk, and where the field is heading next.
This is not a niche anymore. This is mainstream cardiology.

Wonderful session with @ManuelaFiuza5
@andreia_spm @Mariana68137947 Catarina Neves and Eduardo Vilela

@spcardio
#CPCinmotion #CardioOncology

[TCTMD @TCTMD]

On this Beyond the Data, @mmamas1973, @mnobremenezes, and Pietro Ameri talk about the special considerations for treating cancer patients with coronary heart disease during the recent #EAPCI Summit in Munich. Watch the full video now: https://t.co/A8cf3lc26P
@escardio
#EAPCI26

[Consejo de Cardio-Oncología SAC @CardiOncoSAC]

Hoy comentamos una revisión actual de enfermedad cardiovascular en pacientes con leucemia mieloide crónica tratados con ITK.

[@SN_Oncology @SN_Oncology]

🚨Recently Published in #CardioOncology

Association between systemic inflammation and risk of atrial fibrillation in cancer survivors: a population-based cohort study using UK biobank🫀

Read more➡️https://t.co/DrWJxR2mAq
@ICOSociety #OpenAccess #CardioOnc

[Raul Cordoba, MD, PhD #EHA2026 @DrRaulCordoba]

#Hematology Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients #bmtsm #CardioOnc https://t.co/1ubmdbZo1p

[Raul Cordoba, MD, PhD #EHA2026 @DrRaulCordoba]

#Hematology Ten-year predictive performance of cardiovascular risk models in adult survivors of allogeneic hematopoietic stem-cell transplant #bmtsm #CardioOnc https://t.co/uJWbkFFJG5

[Professor Arjun Ghosh (London Cardio-Oncology) @arjunkg]

An important figure from our paper. #CardioOncology can be combined with any aspect of #cardiology training. All subspecialties are welcome and needed! @BritishCardioSo @TheBJCA @RCPhysicians @escardio @JACCJournals @ICOSociety

[Sociedade Portuguesa de Cardiologia @spcardio]

ASociedade Portuguesa de Cardiologia criou esta petição para reforçar a importância de permitir o acesso a medicamentos que aumentam a longevidade e melhoram a qualidade de vida das pessoas com doença cardiovascular, especificamente os agonistas do recetor do GLP-1, particularmente relevantes em pessoas com obesidade.

Apesar da evidência científica 📚, em Portugal os cardiologistas continuam impedidos de prescrever estes medicamentos no contexto da prevenção cardiovascular ⚠️.

Alargar o acesso a terapêuticas eficazes é uma medida essencial de saúde pública 🩺.

👉 Assina a petição em https://t.co/jHnoOsbazw

[The Lancet @TheLancet]

Can small changes in physical activity make a major difference?

On the cover, a meta-analysis suggests that 5 extra minutes of moderate physical activity a day is associated with a reduction of up to 6% of all deaths in the least active adults.

Read this & more 👉 https://t.co/CjW7g8x8JG

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🌍Cardio-Oncology at the Heart of Cancer Care
The ESC CRT on #CardioOncology just concluded—with academia, regulators, industry & patients to shape a roadmap for CV safety,monitoring& survivorship.
Next stop➡️Vienna🇦🇹at #ESCardioOnco2026 to keep the momentum going. Don’t miss it!

[Sociedade Portuguesa de Cardiologia @spcardio]

Na mais recente edição da revista SÁBADO, a saúde do coração ganha destaque. 🫀
A Prof.ª Cristina Gavina, presidente da Sociedade Portuguesa de Cardiologia, e outros especialistas explicam como a prevenção, o diagnóstico precoce e a inovação estão a mudar o futuro da saúde cardiovascular.

⚠️ De acordo com a cardiologista, que dá rosto a este número, “a maior parte das pessoas não se apercebe porque não dói”, o que torna a prevenção ainda mais determinante.

Pode ler o artigo em https://t.co/RpYZ6FyCnT

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

The 2nd Edition of #ESCardioOnco26 is back!🫀

Join the global #cardiooncology community in Vienna, 19–20 June 2026!📚

⏰ Key deadlines you don’t want to miss:
- 29 Jan 2026: Abstract submission
- 05 Feb 2026: Clinical case

🔗 Submit now!: https://t.co/ThuFp5hklX

@escardio

[European Society of Cardiology @escardio]

❤️ Be at the heart of the conversation at #ESCardioOnco26 by submitting your abstract or clinical case today! 💙

Take the opportunity to elevate your impact and inspire fellow professionals from across the cardio-oncology community 👉 https://t.co/Yyonk4OQ72

@TeresaLpezFdez1 @slumberbell @DrRaulCordoba @BerglerKlein @FarmakisD @CiroSantoro17 #ESCCardioOnco

[@SN_Oncology @SN_Oncology]

🚨Recently Published in #CardioOncology

Breast cancer progression in the presence of treated and untreated left ventricular dysfunction🫀

Read more➡️https://t.co/HwlCeGmoa0
@ICOSociety #OpenAccess

[DrJE-Salem @DrJESalem]

Risk of QTc prolongation, and major cardiovascular adverse events associated with CDK4/6 inhibitors in hormone receptor-positive HER2-negative breast cancer—a systematic review and meta-analysis https://t.co/fmLpeOakwZ

[JACC Journals @JACCJournals]

🫀✨ Classic Hodgkin lymphoma is highly curable, but anthracyclines & thoracic radiation can leave lifelong cardiac scars. Early CV risk assessment + cardio-protective strategies + multidisciplinary care = saving lives & hearts 💪 https://t.co/hgj87JD2BZ

#JACCCardioOnc #lymsm

[International Cardio-Oncology Society @ICOSociety]

📞 Calling all Imaging Experts - we need your help. Please fill out this survey to help us understand your successes and challenges in cardiac imaging for cancer patients.

Link: https://t.co/rBRIo0ZBo3

#cardioonc #cardiacimaging #cardiooncology #cardiology #oncology #cancertreatment

[Mamas A. Mamas @mmamas1973]

Our PRECISE-DAPT Cancer score now validated in a Swedish Cohort (SWEDE-Heart registry) suggesting that the majority of patients with cancer would benefit with short DAPT following ACS / PCI although a few would still benefit from prolonged therapy. We now can better better personalise care in this vulnerable population

Thank you to our swedish collaborators for leading on this @SachariasVK @moman_am @DavidErlinge @MoDafaalla